Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02213770
Other study ID # 2014/872/REK sør-øst C
Secondary ID
Status Completed
Phase N/A
First received August 8, 2014
Last updated January 22, 2016
Start date August 2014
Est. completion date November 2015

Study information

Verified date January 2016
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: Regional Ethics Commitee
Study type Observational

Clinical Trial Summary

High-intensity training (HIT) has repeatedly been documented to have superior positive effects compared to moderate exercise in patients with coronary heart disease and heart failure. Since heart transplant recipients (HTx), have a denervated heart with different respond to exercise, HIT has previously not been introduced among these patients. Rikshospitalet carried out a RCT to investigate this (the TEX study 2009-2012), and found that this form of exercise also was highly effective and safe in long term HTx with clinically significant improvement in VO2peak, muscular exercise capasity, general HRQoL, and even slower progression of CAV (coronary allograft vasculopathy). Based on these findings we ask the following questions in this follow-up study:

1. Would the effect on VO2peak, HRQoL,muscle capacity and CAV obtained during the study period continue during long term follow up (5 years)?

2. Is the intervention group more physical active after HIT compared to the control group?


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- stable situation

- optimal medical treatment

- written concent

Exclusion Criteria:

- unstable situation,

- infections (open wounds or skin diseases),

- physical conditions that prevents participation,

- or other injuries/ diseases who are contraindicated with training.

Study Design

Observational Model: Case-Crossover, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Norway OUS- Rikshospitalet Oslo

Sponsors (2)

Lead Sponsor Collaborator
Oslo University Hospital Norwegian Health Association

Country where clinical trial is conducted

Norway, 

References & Publications (4)

Nytrøen K, Myers J, Chan KN, Geiran OR, Gullestad L. Chronotropic responses to exercise in heart transplant recipients: 1-yr follow-up. Am J Phys Med Rehabil. 2011 Jul;90(7):579-88. doi: 10.1097/PHM.0b013e31821f711d. — View Citation

Nytrøen K, Rustad LA, Aukrust P, Ueland T, Hallén J, Holm I, Rolid K, Lekva T, Fiane AE, Amlie JP, Aakhus S, Gullestad L. High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients. Am J Tran — View Citation

Nytrøen K, Rustad LA, Erikstad I, Aukrust P, Ueland T, Lekva T, Gude E, Wilhelmsen N, Hervold A, Aakhus S, Gullestad L, Arora S. Effect of high-intensity interval training on progression of cardiac allograft vasculopathy. J Heart Lung Transplant. 2013 Nov — View Citation

Nytrøen K, Rustad LA, Gude E, Hallén J, Fiane AE, Rolid K, Holm I, Aakhus S, Gullestad L. Muscular exercise capacity and body fat predict VO(2peak) in heart transplant recipients. Eur J Prev Cardiol. 2014 Jan;21(1):21-9. doi: 10.1177/2047487312450540. Epu — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary mean VO2peak in the intervention group and control group We will use the same test protocol as the TEX- study. 5 years after start of inclusion in RCT (TEX). One measurment. No
Secondary How many has progression of cardiac allograft vasculopathy in the intervention group and control group. Progression of vasculopathy will be studied with IVUS technique, and compared with IVUS pictures from TEX. 5 years after inclusion in RCT (TEX study). No
Secondary Mean muscle capacity in the intervention group and control group. 5 years after inclusion in RCT, TEX study. No
Secondary Quality of life We will use validated questionnaires to estimate quality of life and to evaluate depression. 5 years after inclusion in TEX- study. No
Secondary Difference in activity level between groups To estimate activity the study population will fill out a validated questionnaire about physical activity, and they will wear a physical activity monitor at home for one week. 5 years after inclusion i RCT, TEX study. No
See also
  Status Clinical Trial Phase
Completed NCT02077764 - The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients. N/A
Terminated NCT01278745 - Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation Phase 2
Recruiting NCT06190171 - Respiratory Strength Training in Heart Transplant Recipients N/A
Completed NCT01912248 - Acute Effect of Strength Training on Blood Pressure in Cardiac Patients N/A
Active, not recruiting NCT01759966 - Autonomic Cardiovascular Control After Heart Transplantation
Completed NCT01914406 - High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients. N/A
Completed NCT01796379 - High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia N/A
Completed NCT03662789 - Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients Phase 2/Phase 3